Ysios Capital Launches €100M Fund to Build Biotech Companies from Spanish Science

Ysios Capital, Spain's largest life sciences VC, has launched a new fund of €100 million to build biotech companies from university and research center spinouts.

For those who value deployment on-prem, there are trade-offs between having control over one's infrastructure and the risk of increased technical complexity. Additionally, using specific hardware such as A100 80GB or H100 SXM5 can impact performance.